David Meeker will inherit CEO job at Genzyme

Sanofi has appointed David Meeker CEO of Genzyme, replacing Henri Termeer, effective 1 November 2011. He will report to Christopher Viehbacher, CEO of Sanofi and chair of Genzyme. Under Mr Meeker's leadership Genzyme plans to incorporate the rare disease business and the multiple sclerosis franchise. Mr Meeker has served at Genzyme since 1994, most recently as COO.